81 FR 41321 - Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 122 (June 24, 2016)

The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on July 6-7, 2016. The subject of the meeting will be the ``Artificial Pancreas Workshop: Testing and Adoption of Current and Emerging Technologies.'' The meeting is open to the public.

[Federal Register Volume 81, Number 122 (Friday, June 24, 2016)]
[Notices]
[Page 41321]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-15016]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on July 6-7, 2016. The subject of the 
meeting will be the ``Artificial Pancreas Workshop: Testing and 
Adoption of Current and Emerging Technologies.'' The meeting is open to 
the public.

DATES: The meeting will be held on July 6-7, 2016.

ADDRESSES: The meeting will be held in the NIH campus, 9000 Rockville 
Pike, Bethesda, MD 20892-2560, Lister Hill Auditorium, Building 38A. 
Pre-registration at http://www.niddk.nih.gov/news/events-calendar/Pages/fourth-artificial-pancreas-workshop.aspx is required.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or 
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes 
Mellitus Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; FAX: 301-480-6741; email: [email protected].

SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising 
members of the Department of Health and Human Services and other 
federal agencies that support diabetes-related activities, facilitates 
cooperation, communication, and collaboration on diabetes among 
government entities. DMICC meetings, held several times a year, provide 
an opportunity for Committee members to learn about and discuss current 
and future diabetes programs in DMICC member organizations and to 
identify opportunities for collaboration. The July 6-7, 2016 DMICC 
meeting will focus on testing and adoption of current and emerging 
artificial pancreas technologies.
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC Web site, www.diabetescommittee.gov.

    Dated: June 17, 2016.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2016-15016 Filed 6-23-16; 8:45 am]
 BILLING CODE 4140-01-P